170 related articles for article (PubMed ID: 23233602)
1. How to use new biology to guide therapy in multiple myeloma.
Morgan GJ; Kaiser MF
Hematology Am Soc Hematol Educ Program; 2012; 2012():342-9. PubMed ID: 23233602
[TBL] [Abstract][Full Text] [Related]
2. Advances in biology and therapy of multiple myeloma.
Barillé-Nion S; Barlogie B; Bataille R; Bergsagel PL; Epstein J; Fenton RG; Jacobson J; Kuehl WM; Shaughnessy J; Tricot G
Hematology Am Soc Hematol Educ Program; 2003; ():248-78. PubMed ID: 14633785
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma.
Harousseau JL; Shaughnessy J; Richardson P
Hematology Am Soc Hematol Educ Program; 2004; ():237-56. PubMed ID: 15561686
[TBL] [Abstract][Full Text] [Related]
4. Genetic heterogeneity in multiple myeloma.
Magrangeas F; Lodé L; Wuilleme S; Minvielle S; Avet-Loiseau H
Leukemia; 2005 Feb; 19(2):191-4. PubMed ID: 15538406
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for multiple myeloma in the era of novel therapies.
Ziogas DC; Dimopoulos MA; Kastritis E
Expert Rev Hematol; 2018 Nov; 11(11):863-879. PubMed ID: 30334460
[TBL] [Abstract][Full Text] [Related]
6. [Advances in multiple myeloma molecular biology research].
Hanamura I
Rinsho Ketsueki; 2019; 60(9):1236-1242. PubMed ID: 31597849
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
8. Utilizing next-generation sequencing in the management of multiple myeloma.
Lionetti M; Neri A
Expert Rev Mol Diagn; 2017 Jul; 17(7):653-663. PubMed ID: 28524737
[TBL] [Abstract][Full Text] [Related]
9. Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for higher risk settings.
Richardson PG; Laubach J; Mitsiades CS; Schlossman R; Hideshima T; Redman K; Chauhan D; Ghobrial IM; Munshi N; Anderson KC
Br J Haematol; 2011 Sep; 154(6):755-62. PubMed ID: 21732930
[TBL] [Abstract][Full Text] [Related]
10. Strategies for risk-adapted therapy in myeloma.
Fonseca R
Hematology Am Soc Hematol Educ Program; 2007; ():304-10. PubMed ID: 18024644
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell leukemia: from biology to treatment.
Jelinek T; Kryukov F; Rihova L; Hajek R
Eur J Haematol; 2015 Jul; 95(1):16-26. PubMed ID: 25778450
[TBL] [Abstract][Full Text] [Related]
12. Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.
Chandesris MO; Soulier J; Labaume S; Crinquette A; Repellini L; Chemin K; Malphettes M; Fieschi C; Asli B; Uzunhan Y; Fermand JP; Bories JC; Arnulf B
Br J Haematol; 2007 Feb; 136(4):609-14. PubMed ID: 17223917
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential.
Paíno T; Paiva B; Sayagués JM; Mota I; Carvalheiro T; Corchete LA; Aires-Mejía I; Pérez JJ; Sanchez ML; Barcena P; Ocio EM; San-Segundo L; Sarasquete ME; García-Sanz R; Vidriales MB; Oriol A; Hernández MT; Echeveste MA; Paiva A; Blade J; Lahuerta JJ; Orfao A; Mateos MV; Gutiérrez NC; San-Miguel JF
Leukemia; 2015 May; 29(5):1186-94. PubMed ID: 25388955
[TBL] [Abstract][Full Text] [Related]
14. Investigative tools for diagnosis and management.
Munshi NC
Hematology Am Soc Hematol Educ Program; 2008; ():298-305. PubMed ID: 19074100
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling.
Stewart AK; Fonseca R
J Clin Oncol; 2005 Sep; 23(26):6339-44. PubMed ID: 16155017
[TBL] [Abstract][Full Text] [Related]
16. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival.
Palumbo A; Attal M; Roussel M
Clin Cancer Res; 2011 Mar; 17(6):1253-63. PubMed ID: 21411441
[TBL] [Abstract][Full Text] [Related]
17. Biology and treatment of myeloma.
Brioli A; Melchor L; Walker BA; Davies FE; Morgan GJ
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S65-70. PubMed ID: 25486959
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in multiple myeloma: practicability for clinical practice and future perspectives.
Haferlach T; Löffler H
Leukemia; 1997 Dec; 11 Suppl 5():S5-9. PubMed ID: 9436931
[TBL] [Abstract][Full Text] [Related]
19. Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing.
Ryland GL; Jones K; Chin M; Markham J; Aydogan E; Kankanige Y; Caruso M; Guinto J; Dickinson M; Prince HM; Yong K; Blombery P
J Clin Pathol; 2018 Oct; 71(10):895-899. PubMed ID: 29760015
[TBL] [Abstract][Full Text] [Related]
20. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
